ImmuCell Corp. (ICCC)
10.25
-0.19
(-1.82%)
USD |
NASDAQ |
Oct 23, 16:00
10.25
0.00 (0.00%)
After-Hours: 20:00
ImmuCell Price to Book Value : 2.967 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.967 |
| October 22, 2026 | 3.022 |
| October 21, 2026 | 3.045 |
| October 20, 2026 | 3.025 |
| October 19, 2026 | 3.042 |
| October 16, 2026 | 3.112 |
| October 15, 2026 | 3.057 |
| October 14, 2026 | 3.112 |
| October 13, 2026 | 3.124 |
| October 12, 2026 | 2.779 |
| October 09, 2026 | 2.837 |
| October 08, 2026 | 2.822 |
| October 07, 2026 | 2.805 |
| October 06, 2026 | 2.886 |
| October 05, 2026 | 2.822 |
| October 02, 2026 | 2.822 |
| October 01, 2026 | 2.779 |
| September 30, 2026 | 2.837 |
| September 29, 2026 | 2.877 |
| September 28, 2026 | 2.86 |
| September 25, 2026 | 2.873 |
| September 24, 2026 | 2.886 |
| September 23, 2026 | 2.892 |
| September 22, 2026 | 2.892 |
| September 21, 2026 | 2.932 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.880 |
| September 17, 2026 | 2.889 |
| September 16, 2026 | 2.782 |
| September 15, 2026 | 2.773 |
| September 14, 2026 | 2.811 |
| September 11, 2026 | 2.851 |
| September 10, 2026 | 2.870 |
| September 09, 2026 | 2.869 |
| September 08, 2026 | 2.848 |
| September 04, 2026 | 2.866 |
| September 03, 2026 | 2.895 |
| September 02, 2026 | 2.895 |
| September 01, 2026 | 2.872 |
| August 31, 2026 | 2.834 |
| August 28, 2026 | 2.877 |
| August 27, 2026 | 2.901 |
| August 26, 2026 | 2.901 |
| August 25, 2026 | 2.848 |
| August 24, 2026 | 2.848 |
| August 21, 2026 | 2.912 |
| August 20, 2026 | 2.921 |
| August 19, 2026 | 2.932 |
| August 18, 2026 | 2.825 |
| August 17, 2026 | 2.808 |
| August 14, 2026 | 2.909 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| PE Ratio | 122.32 |
| PS Ratio | 3.035 |
| Price to Free Cash Flow | 22.09 |
| Price | 10.25 |
| Earnings Yield | 0.82% |
| Market Cap | 93.09M |
| Operating PE Ratio | 49.88 |
| Normalized PE Ratio | 74.33 |